RaQualia Pharma Inc.

4579

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-14FY2026 Q2

Revenue

39100M JPY

YoY +20.7%

Operating Income

-3.4100M JPY

YoY -78.0%

Net Income

1.6100M JPY

YoY +130.7%

EPS

-18.1JPY

YoY -16.8%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

39.8億円

28.6億円

17.4億円

6.2億円

-5億円

Rev: 27.8億円Op: 7.1億円NI: 7.6億円

Rev: 29.2億円Op: 8.7億円NI: 7.2億円

Rev: 19億円Op: -3.4億円NI: -3.2億円

Rev: 31.1億円Op: -2.1億円NI: -5億円

Rev: 39.8億円Op: 4.8億円NI: 2.7億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income740.7%

Revenue Progress14.600M

Revenue Forecast39.800M

Net Income Progress-4.700M

Net Income Forecast-63M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan